Pari Homepage

Results will be updated as you type

News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

Digital illustration of lungs with connected data structures and technical graphics, featuring the eFlow® Technology logo.

Categories

  • PARI News
  • Partner News
  • PARI Publications
  • Publications
  • eFlow Integrated

Posts of category: Partner News

Recent announcements, achievements, and development milestones from PARI's pharmaceutical partners utilizing eFlow® Technology.

Published
March 17, 2026
Category
  • Partner News

Savara Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) for MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

Published
March 10, 2026
Category
  • Partner News

Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease

Published
March 5, 2026
Category
  • Partner News

Avalyn Announces First Patient Dosed in AURA Phase 2 Clinical Trial Evaluating AP02, Inhaled Nintedanib, for the Treatment of Idiopathic Pulmonary Fibrosis

Published
December 2, 2025
Categories
  • PARI News
  • Partner News

Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System

Published
October 30, 2025
Categories
  • PARI News
  • Partner News

Customization is key

Previous page
of 11
Next page

Back to overview

  1. eFlow Partnering
  2. News & Publications
  3. Categories
Link to PARI at LinkedIn

+49 (0) 8151 279 279
 

Contact

  • Career
  • Press portal
  • Partner with us
  • PARI INT
  • Imprint
  • Data Protection
  • Cookie Consent
  • Accessibility Statement
  • General Terms and conditions

© 2026 PARI GmbH Spezialisten für effektive Inhalation